US 9926557
Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA
granted A61KA61K31/56A61K31/57
Quick answer
US patent 9926557 (Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN TECHNOLOGIES B.V.
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/56, A61K31/57, A61K31/573, A61K31/58